用Theranova透析器扩展血液透析和在开始长期血液透析的患者残留功能:一个随机对照试验
Jeong-Hoon Lim1, Yu Jin Seo2, Yena Jeon3
1Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Journal of the American Society of Nephrology : JASN
|March 4, 2025
概括
与高流量透析器相比,使用Theranova中等切断透析器扩展的血液透析更好地保持残留功能,并减少开始长期血液透析的患者的中分子毒素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 脏替代疗法治疗 脏替代疗法
- 透析技术 透析技术
背景情况:
- 扩展血液透析使用中等切断透析器来增强中分子毒素清除比传统方法.
- 对于开始长期血液透析的患者来说,保持脏残留功能至关重要.
研究的目的:
- 评估使用Theranova中等切断透析器扩展血液透析对新长期血液透析患者残留功能的影响.
- 为了比较Theranova与高流量透析器在保持功能和清除毒素方面的疗效.
主要方法:
- 一个随机试验,涉及80名患者开始长期血液透析.
- 患者被分配给Theranova 400或高流量透析器12个月.
- 主要结局:质过率 (GFR) 的变化;次要结局:尿量,中间分子和损伤标志物.
主要成果:
- 与高流量组相比,Theranova组在12个月内GFR的下降明显较小 (-1,4毫升/分钟每1.73米2).
- 德拉诺瓦在9个月内保持了更大的24小时尿量,并显示了特定的中间分子和损伤标志物的更高减少比率.
- 两组之间没有观察到住院率或死亡率的显著差异.
结论:
- 使用Theranova透析器扩展的血液透析有效地减缓了开始长期血液透析的患者残留功能下降.
- 与标准高流量透析器相比,Theranova在毒素清除和功能维护方面具有潜在的好处.
相关概念视频
01:27Dialysis
247
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247
01:22Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363